BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6810285)

  • 1. [Practical problems raised by antibiotic minimal inhibitory concentration determination in Legionella species (author's transl)].
    Bornstein N; Roudier C; Fleurette J
    Pathol Biol (Paris); 1982 Jun; 30(6):421-5. PubMed ID: 6810285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of an automated procedure determining the minimum inhibitory concentrations (MIC). ].
    Thabaut A; Durosoir JL; Meyran M
    Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):555-9. PubMed ID: 6750524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility of Pittsburgh pneumonia agent (Legionella micdadei) and other newly recognized members of the genus Legionella to nineteen antimicrobial agents.
    Pasculle AW; Dowling JN; Weyant RS; Sniffen JM; Cordes LG; Gorman GM; Feeley JC
    Antimicrob Agents Chemother; 1981 Dec; 20(6):793-9. PubMed ID: 7325645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of the activity on Legionella of eight macrolides and related agents by comparative testing on three media.
    Bornstein N; Roudier C; Fleurette J
    J Antimicrob Chemother; 1985 Jan; 15(1):17-22. PubMed ID: 3972756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of gatifloxacin, compared with ciprofloxacin, clarithromycin, erythromycin, and rifampin, against Legionella species.
    Dubois J; St-Pierre C
    Diagn Microbiol Infect Dis; 1999 Apr; 33(4):261-5. PubMed ID: 10212753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effectiveness of the antibiotics chloramphenicol and rifampin in the treatment of Streptococcus pneumoniae-induced meningitis and systemic infections].
    Hernández M; Mejía GI; Trujillo H; Robledo J
    Biomedica; 2003 Dec; 23(4):456-61. PubMed ID: 14968923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activities of tigecycline and comparators against Legionella pneumophila and Legionella micdadei extracellularly and in human monocyte-derived macrophages.
    Bopp LH; Baltch AL; Ritz WJ; Michelsen PB; Smith RP
    Diagn Microbiol Infect Dis; 2011 Jan; 69(1):86-93. PubMed ID: 21146719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of pazufloxacin, tosufloxacin and other quinolones against Legionella species.
    Higa F; Akamine M; Haranaga S; Tohyama M; Shinzato T; Tateyama M; Koide M; Saito A; Fujita J
    J Antimicrob Chemother; 2005 Dec; 56(6):1053-7. PubMed ID: 16260445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro antibiotic susceptibility of Legionellaceae: search for alternative antimicrobial drugs.
    Traub WH; Spohr M
    Chemotherapy; 1984; 30(3):182-7. PubMed ID: 6734305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of Legionella species to antimicrobial agents.
    Chen SC; Paul ML; Gilbert GL
    Pathology; 1993 Apr; 25(2):180-3. PubMed ID: 8367199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibacterial activity in vitro of 10 quinolones against 20 strains of Legionella pneumophila].
    Deforges L; Fournet MP; Soussy CJ; Duval J
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):631-3. PubMed ID: 3534757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of lomefloxacin (NY-198 or SC 47111), ciprofloxacin, and erythromycin against 100 clinical Legionella strains.
    Edelstein PH; Gaudet EA; Edelstein MA
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):93S-95S. PubMed ID: 2791505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The in-vitro activity of moxifloxacin against Legionella species and the effects of medium on susceptibility test results.
    Ruckdeschel G; Dalhoff A
    J Antimicrob Chemother; 1999 May; 43 Suppl B():25-9. PubMed ID: 10382872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of levofloxacin, erythromycin or rifampicin pretreatment on growth of Legionella pneumophila in human monocytes.
    Smith RP; Baltch AL; Franke M; Hioe W; Ritz W; Michelsen P
    J Antimicrob Chemother; 1997 Nov; 40(5):673-8. PubMed ID: 9421315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of Legionella species to five antibiotics and development of resistance by exposure to erythromycin, ciprofloxacin, and rifampicin.
    Nielsen K; Bangsborg JM; Høiby N
    Diagn Microbiol Infect Dis; 2000 Jan; 36(1):43-8. PubMed ID: 10744366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative multicenter study of 2 methods of determining sensitivity to antibiotics. Gel diffusion method and semiautomatic method in fluid ABAC medium].
    Brun Y; Chanal M; Durosoir JL; Schott P; Sirot D; Saliou P; Coulet M; Thabaut A; Cluzel R; Fleurette J
    Pathol Biol (Paris); 1984 Jan; 32(1):29-34. PubMed ID: 6422428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro activity of RP 59500, a new synergic antibacterial agent, against Legionella spp.
    Dubois J; Joly JR
    J Antimicrob Chemother; 1992 Jul; 30 Suppl A():77-81. PubMed ID: 1399954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic susceptibilities of Legionella pneumophila strain Paris in THP-1 cells as determined by real-time PCR assay.
    Roch N; Maurin M
    J Antimicrob Chemother; 2005 Jun; 55(6):866-71. PubMed ID: 15883178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mupirocin resistance among Iranian isolates of Staphylococcus aureus.
    Saderi H; Owlia P; Habibi M
    Med Sci Monit; 2008 Oct; 14(10):BR210-3. PubMed ID: 18830185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial susceptibility of Legionella pneumophila Serogroups I--IV.
    Saravolatz LD; Pohlod DJ; Quinn EL
    Scand J Infect Dis; 1980; 12(3):215-9. PubMed ID: 7433921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.